{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T09:33:37Z","timestamp":1753522417545,"version":"3.41.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Jpn J Ophthalmol"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s10384-025-01185-4","type":"journal-article","created":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T06:53:39Z","timestamp":1742194419000},"page":"417-424","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Remarkable visual improvement in Leber hereditary optic neuropathy"],"prefix":"10.1007","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7971-8258","authenticated-orcid":false,"given":"Yasuyuki","family":"Takai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Yamagami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayumi","family":"Iwasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryoma","family":"Yasumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Wakakura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,17]]},"reference":[{"key":"1185_CR1","first-page":"1165","volume":"9","author":"C Meyerson","year":"2015","unstructured":"Meyerson C, Van Stavern G, McClelland C. Leber hereditary optic neuropathy: current perspectives. Clin Ophthalmol. 2015;9:1165\u201376.","journal-title":"Clin Ophthalmol"},{"key":"1185_CR2","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1097\/WNO.0000000000001045","volume":"40","author":"NJ Newman","year":"2020","unstructured":"Newman NJ, Carelli V, Taiel M, Yu-Wai-Man P. Visual outcomes in Leber hereditary optic neuropathy patients with the m.11778G>A (MTND4) mitochondrial DNA mutation. J Neuroophthalmol. 2020;40:547\u201357.","journal-title":"J Neuroophthalmol"},{"key":"1185_CR3","first-page":"96","volume":"39","author":"Y Hotta","year":"1995","unstructured":"Hotta Y, Fujiki K, Hayakawa M, Nakajima A, Kanai A, Mashima Y, et al. Clinical features of Japanese Leber\u2019s hereditary optic neuropathy with 11778 mutation of mitochondrial DNA. Jpn J Ophthalmol. 1995;39:96\u2013108.","journal-title":"Jpn J Ophthalmol"},{"key":"1185_CR4","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s12886-017-0583-3","volume":"17","author":"Y Mashima","year":"2017","unstructured":"Mashima Y, Kigasawa K, Shinoda K, Wakakura M, Oguchi Y. Visual prognosis better in eyes with less severe reduction of visual acuity one year after onset of Leber hereditary optic neuropathy caused by the 11,778 mutation. BMC Ophthalmol. 2017;17:192.","journal-title":"BMC Ophthalmol"},{"key":"1185_CR5","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1136\/bjo.84.5.534","volume":"84","author":"M Nakamura","year":"2000","unstructured":"Nakamura M, Yamamoto M. Variable pattern of visual recovery of Leber\u2019s hereditary optic neuropathy. Br J Ophthalmol. 2000;84:534\u20135.","journal-title":"Br J Ophthalmol"},{"key":"1185_CR6","first-page":"339","volume":"119","author":"M Nakamura","year":"2015","unstructured":"Nakamura M, Mimura O, Wakakura M, Inatani M, Nakazawa T, Shiraga F. Designation criteria for Leber\u2019s hereditary optic neuropathy. Nippon Ganka Gakkai Zasshi. 2015;119:339\u201346 ((in Japanese)).","journal-title":"Nippon Ganka Gakkai Zasshi"},{"key":"1185_CR7","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s10384-020-00789-2","volume":"65","author":"H Ishikawa","year":"2021","unstructured":"Ishikawa H, Masuda Y, Ishikawa H, Shikisima K, Goseki T, Kezuka T, et al. Characteristics of Japanese patients with Leber\u2019s hereditary optic neuropathy and idebenone trial: a prospective, interventional, non-comparative study. Jpn J Ophthalmol. 2021;65:133\u201342.","journal-title":"Jpn J Ophthalmol"},{"key":"1185_CR8","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.ophtha.2004.06.034","volume":"112","author":"P Barboni","year":"2005","unstructured":"Barboni P, Savini G, Valentino ML, Montagna P, Cortelli P, De Negri AM, et al. Retinal nerve fiber layer evaluation by optical coherence tomography in Leber\u2019s hereditary optic neuropathy. Ophthalmology. 2005;112:120\u20136.","journal-title":"Ophthalmology"},{"key":"1185_CR9","doi-asserted-by":"publisher","first-page":"8997","DOI":"10.3892\/mmr.2017.7734","volume":"16","author":"Y Ji","year":"2017","unstructured":"Ji Y, Qiao L, Liang X, Zhu L, Gao Y, Zhang J, et al. Leber\u2019s hereditary optic neuropathy is potentially associated with a novel m.5587T>C mutation in two pedigrees. Mol Med Rep. 2017;16:8997\u20139004.","journal-title":"Mol Med Rep"},{"key":"1185_CR10","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.ophtha.2017.01.002","volume":"124","author":"TJ Hwang","year":"2017","unstructured":"Hwang TJ, Karanjia R, Moraes-Filho MN, Gale J, Chu ER, Salomao SR, et al. Natural history of conversion of Leber\u2019s hereditary optic neuropathy: a prospective case series. Ophthalmology. 2017;124:843\u201350.","journal-title":"Ophthalmology"},{"key":"1185_CR11","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1186\/s40064-016-2540-7","volume":"5","author":"R Ran","year":"2016","unstructured":"Ran R, Yang S, He H, Ma S, Chen Z, Li B. A retrospective analysis of characteristics of visual field damage in patients with Leber\u2019s hereditary optic neuropathy. Springerplus. 2016;5:843.","journal-title":"Springerplus"},{"key":"1185_CR12","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/S0021-5155(02)00562-2","volume":"46","author":"Y Mashima","year":"2002","unstructured":"Mashima Y, Sato EA, Ohde H, Oguchi Y. Macular nerve fibers temporal to fovea may have a greater potential to recover function in patients with Leber\u2019s hereditary optic neuropathy. Jpn J Ophthalmol. 2002;46:660\u20137.","journal-title":"Jpn J Ophthalmol"},{"key":"1185_CR13","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1159\/000487485","volume":"60","author":"JJ Yuan","year":"2018","unstructured":"Yuan JJ, Zhang Y, Wang LL, Cheng MS, Ma SQ, Gao Q, et al. Visual field variability after gene therapy for Leber\u2019s hereditary optic neuropathy. Ophthalmic Res. 2018;60:176\u201384.","journal-title":"Ophthalmic Res"},{"key":"1185_CR14","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10384-009-0743-y","volume":"53","author":"M Wakakura","year":"2009","unstructured":"Wakakura M, Fujie W, Emoto Y. Initial temporal field defect in Leber hereditary optic neuropathy. Jpn J Ophthalmol. 2009;53:603\u20137.","journal-title":"Jpn J Ophthalmol"},{"key":"1185_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000535537","volume":"67","author":"M Kishi","year":"2024","unstructured":"Kishi M, Ueda K, Kurimoto T, Nakamura M. Correlation between residual sensitivity in the central inferior nasal visual field and visual function in chronic Leber hereditary optic neuropathy patients. Ophthalmic Res. 2024;67:1\u20138.","journal-title":"Ophthalmic Res"},{"key":"1185_CR16","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.preteyeres.2003.10.003","volume":"23","author":"V Carelli","year":"2004","unstructured":"Carelli V, Ross-Cisneros FN, Sadun AA. Mitochondrial dysfunction as a cause of optic neuropathies. Prog Retin Eye Res. 2004;23:53\u201389.","journal-title":"Prog Retin Eye Res"},{"key":"1185_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.661938","volume":"12","author":"US Kim","year":"2021","unstructured":"Kim US, Mahroo OA, Mollon JD, Yu-Wai-Man P. Retinal ganglion cells: diversity of cell types and clinical relevance. Front Neurol. 2021;12: 661938.","journal-title":"Front Neurol"},{"key":"1185_CR18","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.ophtha.2009.07.026","volume":"117","author":"P Barboni","year":"2010","unstructured":"Barboni P, Carbonelli M, Savini G, CdoV Ramos, Carta A, Berezovsky A. Natural history of Leber\u2019s hereditary optic neuropathy: longitudinal analysis of the retinal nerve fiber layer by optical coherence tomography. Ophthalmology. 2010;117:623\u20137.","journal-title":"Ophthalmology"},{"key":"1185_CR19","doi-asserted-by":"publisher","first-page":"e730","DOI":"10.1111\/aos.14379","volume":"98","author":"HL Liu","year":"2020","unstructured":"Liu HL, Yuan JJ, Zhang Y, Tian Z, Li X, Wang D, et al. Factors associated with rapid improvement in visual acuity in patients with Leber\u2019s hereditary optic neuropathy after gene therapy. Acta Ophthalmol. 2020;98:e730\u20133.","journal-title":"Acta Ophthalmol"},{"key":"1185_CR20","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/0140-6736(92)91442-B","volume":"340","author":"Y Mashima","year":"1992","unstructured":"Mashima Y, Hiida Y, Oguchi Y. Remission of Leber\u2019s hereditary optic neuropathy with idebenone. Lancet. 1992;340:368\u20139.","journal-title":"Lancet"}],"container-title":["Japanese Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-025-01185-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10384-025-01185-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-025-01185-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T05:17:42Z","timestamp":1748582262000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10384-025-01185-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,17]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["1185"],"URL":"https:\/\/doi.org\/10.1007\/s10384-025-01185-4","relation":{},"ISSN":["0021-5155","1613-2246"],"issn-type":[{"type":"print","value":"0021-5155"},{"type":"electronic","value":"1613-2246"}],"subject":[],"published":{"date-parts":[[2025,3,17]]},"assertion":[{"value":"15 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Y. Takai, Lecture fee (Otsuka, Viatris, Senju); A. Yamagami, Speaking engagements (Teijin, Chugai, Santen); M. Iwasa, None; K. Inoue, Grants or contracts (Santen, Teijin, Ono), Lecture fee (Senju, Otsuka, Kowa, Santen, Allergan, Novartis, Chugai, Viatris, Rohto Nitten); R. Yasumoto, None; H. Ishikawa, None; M. Wakakura, Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events (Alexion, Teijin).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}